Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples